CD79A and chronic kidney disease: The prevalence of anti-B2GP1 antibodies of IgA isotype (IgA-aB2GP1) is higher in patients with chronic kidney disease than in the general population (30 vs. 1.5%) (11), and an association between these antibodies in patients undergoing hemodialysis and thrombotic events and mortality has been found (12, 13).